BRCA2 and ovarian neoplasm: In this study, individual ovarian tumor cells revealed the heterogeneity involved in resistance mechanisms, rewiring the HRR pathway, regaining replication fork capacity and protection, and the upregulation of drug efflux pump MDR genes independent of BRCA1/BRCA2 levels.